Barriers to access to antiretroviral treatment in Mozambique

Mozambique faces one of the highest HIV/AIDS prevalences in Africa. Although anti-retroviral therapy is now available, only 7% of those in need actually receive treatment. This project identifies the behavioral, cultural, socio-economic, financial and institutional barriers to treatment through a range of studies using different survey techniques (focus group discussions and household surveys including HIV/AIDS patients, institutional analysis etc).

The project undertakes analysis in both rural and urban areas, and provides information to policy makers to develop approaches to improve the uptake of anti-retrovirals in Mozambique, and is expected to result in a PhD in 2012.

This project is funded by NUFFIC/NTP, and runs till 2012.

Staff Members involved:
Related publications: